Skip to content
Log in
Sponsored Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt Design Multi-Agent AI Systems Using MCP and A2A: Engineer your own Pyt
Review

Increased Cardiovascular Risk in Breast Cancer Patients

Ana Flávia P. D. de Almeida Beatriz de L. Moura Luana Casagranda P. Henrique Macedo Waldemar Augusto de Almeida R. Marques Gomes Sagratzki Gabriel Girão de Araújo Savigny Paulino M. Rodrigues Aloiso Sampaio Souza
· 0 citations · 10 references

TL;DR

The integration between cardiology and oncology, with individualized risk stratification and longitudinal follow-up, are essential for reducing cardiovascular morbidity and mortality among breast cancer patients and survivors.

Semantic Scholar
View source

Similar papers

Review Open access Sep 2026

Metabolic Outcome and CV Risk in Breast Cancer Patients

Breast cancer [BC] is the most diagnosed cancer among women worldwide. Thanks to advancements in early detection, systemic therapies, and supportive care, survival rates have significantly improved. As more patients survive BC, cardiovascular disease [CVD] has emerged as a leading cause of long-term morbidity and morta...

F. Felicetti, G. Mittica, C. Cavallin et al. · 0 citations
Review Aug 2026

Risk factors for cardiovascular diseases and predictors of complications in patients with lung cancer

It is recommended that patients with lung cancer undergo screening to assess their cardiovascular risk and related complications and it is recommended that patients with lung cancer undergo screening to assess their cardiovascular risk and related complications.

M. Mamedov, P. Skopin, A. K. Karimov · 0 citations
Aug 2026

Cardiovascular disease in breast cancer patients receiving chemotherapy: epidemiology and risk factors

Evaluating the occurrence of new-onset CVD in women with breast cancer undergoing chemotherapy and identifying factors associated with increased risk of cardiovascular disease highlights the need for sustained cardiovascular surveillance in breast cancer survivors.

V. Dvorovy, L. Kováčová, M. Selvek et al. · 0 citations
Aug 2026

Insufficient control of classical atherosclerotic risk factors in patients with non-metastatic breast cancer referred for anticancer therapy

Women with non-metastatic breast cancer frequently present with suboptimal control of cardiovascular risk factors at the time of qualification for anticancer therapy, and cardio-oncology care should focus on optimal blood pressure management and aggressive modification of metabolic risk factors, including obesity and d...

S. Mędrek, S. Szmit · 0 citations
Review Open access Aug 2026

Cardiovascular Risk Stratification and Surveillance in Cardio-Oncology: Mechanistic Foundations and Future Directions

Cardio-oncology has emerged as a critical discipline in modern medicine due to the growing population of cancer survivors and the increasing recognition of cardiovascular disease as a major cause of morbidity and mortality in this population. While there have been significant advances in chemotherapy such as advances i...

Aryan Gajjar, S. Shah, A. Gajjar et al. · 0 citations
Review Open access Aug 2026

Resectable Esophageal Cancer Therapy-Related Cardiac Dysfunction: A Review of Mechanisms and Predictive Tools

Esophageal cancer (EC), a highly lethal malignancy with over 445 000 deaths globally in 2022, ranks among the leading causes of cancer mortality globally. As survival improves in EC, cancer therapy-related cardiac dysfunction (CTRCD) has emerged as an important cause of morbidity and mortality. Contemporary treatment s...

U. Anosike, Roy Olunga, Emmanuel Korir et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.